Ad
Thursday, 25 October 2018
FDA declines to approve pre-filled syringe version of Regeneron's Eylea
Regeneron Pharmaceuticals Inc said on Thursday the U.S. Food and Drug Administration declined to approve a pre-filled syringe version of its blockbuster eye drug Eylea, and has sought additional information regarding its manufacturing and supply processes.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment